Oscar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oscar Health, Inc. on September 8, 2022. The filing serves as a Regulation FD disclosure regarding the Company's scheduled participation in two upcoming healthcare industry conferences.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a notice of upcoming events rather than a financial results report.
Material Changes
No material changes to financial performance or operations are reported in this filing. The Company explicitly states it will reaffirm its full-year 2022 guidance, which was originally issued in February 2022 and most recently reaffirmed in the Q2 2022 results released on August 11, 2022.
Guidance, Outlook, and Management Commentary
- Conference Participation: The Company will present at the 2022 Wells Fargo Healthcare Conference on September 8, 2022, and the 20th Annual Morgan Stanley Global Healthcare Conference on September 12, 2022.
- Guidance Reaffirmation: Management intends to reaffirm the full-year 2022 financial guidance previously issued.
- Access: Presentations will be available via virtual webcast, with instructions available on the Company's investor relations website.
- Risk Factors: The filing includes standard cautionary language regarding forward-looking statements, noting that actual results may differ materially due to risks detailed in the Company's Form 10-Q for the period ended June 30, 2022.
Key Facts for Investor Verification
- Verify the specific full-year 2022 guidance figures in the February 10, 2022, and August 11, 2022, press releases, as this 8-K only confirms their reaffirmation.
- Review the "Risk Factors" section of the Q2 2022 Form 10-Q for details on uncertainties affecting the forward-looking statements.
- Confirm the webcast access details on the investor relations website (ir.hioscar.com) if planning to attend the presentations.